Abstract: A method of treating urinary incontinence is disclosed. The method includes guiding a tip of an introducer tool through a length of a soft tissue anchor and out of an end of the soft tissue anchor. The method includes pushing the tip of the introducer tool and the soft tissue anchor into tissue on a side of a urethra, penetrating the tissue with the tip of the introducer tool, and delivering the soft tissue anchor into the tissue. The method includes removing the tip of the introducer tool from the soft tissue anchor and allowing a plurality of projections connected to the soft tissue anchor to expand thus anchoring the soft tissue anchor in the tissue.

Abstract: A system for delivery of medication in treatment of disorders of the pelvis is disclosed. The system includes a medicament applied to an implantable device and an insertion tool. The implantable device has a first end opposite from a second end, with the first end of the implantable device insertable into tissue within the pelvis. A retrieval string is coupled to the second end of the implantable device. The insertion tool includes a shaft extending between a proximal end and a distal end, with a handle coupled to the proximal end of the insertion tool and the distal end of the insertion tool is adapted to couple with the implantable device. The handle includes a notch adapted to releasably secure the retrieval string.

Abstract: A system for delivery of medication in treatment of disorders of the pelvis is disclosed. The system includes a medicament applied to an implantable device and an insertion tool. The implantable device has a first end opposite from a second end, with the first end of the implantable device insertable into tissue within the pelvis. A retrieval string is coupled to the second end of the implantable device. The insertion tool includes a shaft extending between a proximal end and a distal end, with a handle coupled to the proximal end of the insertion tool and the distal end of the insertion tool is adapted to couple with the implantable device. The handle includes a notch adapted to releasably secure the retrieval string.

Abstract: A device implantable in tissue of a prostate gland or a bladder is described. The device includes a device body, a retrieval portion, a medicament, and a medicament carrier. The device body includes a first end and a second end opposite of the first end. The first end has a sharp tip adapted for penetrating the tissue. The retrieval portion connected to the second end of the device body. The medicament is applied to the device to therapeutically treat the prostate gland or the bladder. The carrier is a hydrogel, a silicone based material, an elastomer, a proteinaceous material, a polyethylene glycol material, a carbohydrate material, or a polysaccharide carbohydrate material that provides controlled delivery of the medicament over a duration of time.

Abstract: A method of treating pelvic organ prolapse in a female patient by accessing a prolapsed organ trans-vaginally through a vagina is disclosed. The method includes making an incision through a wall of a vagina of the female patient, and providing an implant with a mesh having a mass density of 50 g/m2 or less. The method additionally includes radially confining the implant with a tool, and inserting a portion of the tool and the implant through the incision formed in the wall of the vagina. The method includes releasing the implant from the tool in an area of the prolapsed organ in supporting the vagina of the female patient.

Abstract: A device implantable in tissue of a prostate gland or a bladder is described. The device includes a device body, a retrieval portion, a medicament, and a medicament carrier. The device body includes a first end and a second end opposite of the first end. The first end has a sharp tip adapted for penetrating the tissue. The retrieval portion connected to the second end of the device body. The medicament is applied to the device to therapeutically treat the prostate gland or the bladder. The carrier is a hydrogel, a silicone based material, an elastomer, a proteinaceous material, a polyethylene glycol material, a carbohydrate material, or a polysaccharide carbohydrate material that provides controlled delivery of the medicament over a duration of time.

Abstract: A method of treating a vaginal prolapse is provided. The method includes accessing a vaginal prolapse, inserting an implant comprising a knitted mesh into a patient, and securing the knitted mesh in place such that the implant supports the pelvic floor of the patient. The knitted mesh has a mass density of less than 20 g/m2.

Abstract: An implantable delivery device system for delivery of a medicament to a bladder includes a device body, a drug coating disposed over at least a portion of the device body, and an insertion tool. The device body includes a first end and a second end opposite of the first end, the first end having a first diameter and including a sharp tip for penetrating tissue and the second end having a second diameter and including a head portion. The second diameter is larger than the first diameter. The drug coating is disposed over a portion of the device body and is provided for treatment of an over active bladder. The insertion tool has a shaft located between a proximal end of the tool that includes a handle shaft and a distal end of the tool that is attachable to the head of the device.

Abstract: A surgical device that is implantable to treat female urinary incontinence includes a support, a first suspending member connected to the support, a second suspending member connected to the support, a first anchor connected to the first suspending member, and a second anchor connected to the second suspending member. A distance measured along the second suspending member between the second anchor and the support is adjustable.

Abstract: An implant configured to treat prolapse of a pelvic organ includes a support member and an extension portion projecting from the support member. The extension portion has a barbed fixation means provided thereon for anchoring the extension portion into pelvic paravaginal tissue. The barbed fixation means allow bi-directional adjustment of the barbed fixation means relative to the tissue, and when suitably located, the barbed fixation means engage the tissue. The support member comprises a mesh material having a mass density of less than 50 g/m2.

Abstract: A method of post-operatively adjusting a urethral support in treating urinary incontinence of a woman is disclosed. The method includes passing a support through an incision and locating the support under a urethra. The support is a porous mesh adapted to allow tissue in-growth. The method include adjusting the support by applying tension to one of a first member that is secured to a first end of the support or a second member that is secured to a second end of the support. The first member and the second member each has an end that exits the skin. The first and second members are adapted to prevent tissue in-growth into the first member and the second member.

Abstract: A surgical implant for treating female urinary incontinence includes a suburethral support, first and second soft tissue anchors, and first and second elongated members connecting the first and second soft tissue anchors to first and second ends of the suburethral support. The first soft tissue anchor includes a central portion, a plurality of projections extending from the central portion, and a plurality of deflection-limiting features. The plurality of projections extends from the central portion, each of the projections being inclined away from a longitudinal axis of the first soft tissue anchor and configured to be deflected inwardly toward the longitudinal axis during delivery. The plurality of deflection-limiting features is configured to limit deflection of the plurality of projections outwardly away from the longitudinal axis beyond a desired angle.

Abstract: A system for treating urinary incontinence includes a suburethral support, first and second soft tissue anchors, and an introducer. The suburethral support is formed of a mesh material, the first and second soft tissue anchors each have a tip, a base, a first face, a second face, a plurality of barbs, and an aperture extending from the first face to the second face. The introducer is configured for delivering the first soft tissue anchor to a desired anchoring site of the pelvis, the introducer having an elongate shaft and a handle, the elongate shaft having a distal portion and a proximal portion, the elongate shaft being coupled at the proximal portion to the handle, the distal portion of the introducer forming a longitudinal recess adapted to receive the first soft tissue anchor such that a portion of the first soft tissue anchor engages a distal most end of the distal portion of the introducer.

Abstract: A urethral stabilization system includes a suspending member attached between a stabilizer and support member. The support member is implantable into a patient to support a urethra. A first suspending member is attached between a first end of the support member and a first stabilizer, and a second suspending member is attached between a second end of the support member and a second stabilizer. A first thread member continuously extends between a first end that is attached to the first stabilizer and a second end of the first thread member that is free, and a second thread member continuously extending between a first end that is attached to the second stabilizer and a second end of the second thread member that is free.

Abstract: An implant configured to treat prolapse of a pelvic organ includes a support member and an extension portion projecting from the support member. The extension portion has a barbed fixation means provided thereon for anchoring the extension portion into pelvic paravaginal tissue. The barbed fixation means allow bi-directional adjustment of the barbed fixation means relative to the tissue, and when suitably located, the barbed fixation means engage the tissue. The support member comprises a mesh material having a mass density of less than 50 g/m2.

Abstract: Master flange assemblies are disclosed herein. In one embodiment, a master flange assembly includes a master flange and a tube. The master flange includes a central aperture, at least one through-hole, and a plurality of cavities. The tube is arranged to pass through the central aperture and form the master flange assembly when secured to the master flange. In one embodiment, the plurality of cavities are recessions formed in a first surface of the master flange, wherein the recessions do not pass through the master flange. In one embodiment, the plurality of cavities are separated by ribs. In one embodiment, the master flange includes a shoulder recessed from a second surface of the master flange and adjacent to the central aperture. The tube includes a rim that engages the shoulder of the master flange when the tube is secured to the master flange to form the assembly.

Abstract: A method assesses an energy impacting event at a facility using an energy management system. One or more energy consuming endpoints of the facility are sub-metered and data from the sub-metered endpoints is transmitted to the energy management system. A project is created within the EMS by entering project definition attributes including at least a site name, a project name, and a start date. Data from one or more sub-metered channels and a project indicator is displayed. The displayed project indicator is located at a point corresponding to its project start time. A further method tracks the progress of energy saving project at a facility using an energy management system. The project definition attributes further include one or more sub-metered channels, baseline usage data, and an energy related goal. An energy impact value is calculated by subtracting the actual sub-metered usage data from the baseline data and a determination is made whether the energy impact value meets or exceeds the energy goal.

Abstract: A surgical implant for treating female urinary incontinence includes a suburethral support, first and second soft tissue anchors, and first and second elongated members connecting the first and second soft tissue anchors to first and second ends of the suburethral support. The first soft tissue anchor includes a central portion, a plurality of projections extending from the central portion, and a plurality of deflection-limiting features. The plurality of projections extends from the central portion, each of the projections being inclined away from a longitudinal axis of the first soft tissue anchor and configured to be deflected inwardly toward the longitudinal axis during delivery. The plurality of deflection-limiting features is configured to limit deflection of the plurality of projections outwardly away from the longitudinal axis beyond a desired angle.

Abstract: A surgical implant for treating female urinary incontinence comprises a suburethral support and first and second polymer soft tissue anchors. The suburethral support has a first end portion and a second end portion located opposite the first end portion. Each of the first and second soft tissue anchors is connected to a respective one of the first and second opposite end portions of the suburethral support. The first and second anchors are configured to penetrate and retain in soft tissue. A length of the implant between the first and second soft tissue anchors is configured to allow the suburetnral support to be positioned below a urethra of a patient and to allow the anchors to be retained in soft tissue on first and second sides of the urethra without the anchors penetrating the abdominal wall.